Rapamycin inhibition of the Akt/mTOR pathway blocks select stages of VEGF-A164-driven angiogenesis, in part by blocking S6Kinase.

Source:http://linkedlifedata.com/resource/pubmed/id/19443844

Download in:

View as

General Info

PMID
19443844